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Abstract 
 
Background: Gnidia capitata L. F.  belongs to the family Thymelaeaceae, and has been widely reported for its 
ethnobotanical uses, especially for the treatment of several human ailments which include skin conditions. However, 
there is limited information about the pharmacological properties of this plant as a potential cosmetic agent or 
pharmaceutical. The aim of this study was to evaluate the therapeutic potential of G. capitata for its anti-tyrosinase, 
antibacterial, antioxidant, anticancer and anti-mycobacterial properties. 
Materials and methods: G. capitata was extracted with methanol (MeOH), ethyl acetate (EtOAc), dichloromethane 
(DCM) and hexane (n-Hex). All extracts were tested in vitro for activities against Propionibacterium acnes (ATCC 
11827) and Mycobacterium tuberculosis H37Rv (ATCC 27294). Tyrosinase inhibitory activity was screened using 
tyrosinase from Agaricus bispor. Antioxidant activity was investigated using the 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) radical scavenging assay.  
Results: EtOAc, DCM and n-Hex extracts of the plant showed antibacterial activity against P. acnes with MICs of 125 
µg/ml. The DCM and n-Hex extracts showed anti-mycobacterial activity with MICs of 500µg/ml. The methanolic 
extract showed the highest antioxidant activity with an IC50 of 41.83µg/ml.  
Conclusion: The findings presented in this study may explain the potential use of G. capitata for the treatment of 
certain skin conditions. The potent antioxidant activity could help control the negative effects associated with 
inflammatory mediators that are produced during the immune response in people that are affected by skin conditions.  
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Introduction 
 
The human skin is the largest organ in the body and forms the first-line of defence against any harmful stimuli. 
There are three distinctive layers of the skin which include the epidermis, dermis and hypodermis (subcutaneous) 
which have unique functions of protection and in maintaining homeostasis (Tabassum and Hamdani, 2014). A number 
of factors including hypersensitivity reactions may trigger skin and subcutaneous tissue disorders (Voie et al., 2012). 
Some individuals suffer several dermatological conditions such as skin dryness, itching, redness, scaly patches and 
lichenified thick plaques with excoriation (Tay et al., 2002; Worm, 2002). Other forms of dermatological conditions 
include mild to severe acne, rashes, lesions, fungal dermatitis, irritations and nail disorders. Adverse dermatological 
conditions may also include skin ulcers, skin nodules, herpes simplex, herpes zoster, and pustular rash (Pharmacare, 
2003; Stevens et al., 2005). These may cause serious discomfort and post inflammatory hyper-pigmentation.  
Acne is one of the most common multifactorial chronic inflammatory diseases of the pilosebaceous follicles 
involving androgen induced sebaceous hyperplasia, altered follicular keratinisation, hormonal imbalance, immune 
hypersensitivity and bacterial colonisation by Propionibacterium acnes (Coenye et al., 2007; Williams et al., 2012). 
The development of inflammatory acne occurs through the activation of complement and metabolizing sebaceous 
triglycerides into fatty acids that irritate the follicular wall and surrounding dermis. P. acnes also produces exo-
enzymes which chemotactically attract neutrophils (Webster, 2002). The clinical manifestations of acne include 
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seborrhoea (excess grease), non-inflammatory lesions (open and closed comedones), inflammatory lesions (papules and 
pustules), and various degrees of scarring due to cyst formation (Williams et al., 2012). Another severe skin condition 
is cutaneous tuberculosis (TB) of the skin which is caused by Mycobacterium tuberculosis. A recent survey showed a 
broader spectrum of skin conditions among patients hospitalized with TB in South Africa and these conditions could be 
exacerbated due to co-infection of TB and HIV (McLachlan et al., 2016). The problem of antibiotic resistance and high 
treatment cost for skin conditions such as acne have led to the search for alternative remedies using medicinal plants. 
 
 
The use of traditional medicinal plants to treat skin conditions is a common practice in many cultures, 
although the precise mechanism of cure is not always understood (Grierson and Afolayan, 1999). The topical 
application of many plant medicines for treatment of various skin conditions has proven effective due to the presence of 
plant secondary metabolites that have potent antimicrobial and antioxidant properties (Quave et al., 2008). These 
secondary metabolites can either eliminate or inhibit the activity of the infectious pathogens (Samy and 
Gopalakrishnakone, 2008). Antioxidants from plants protect against the damaging effects of free radicals generated 
during metabolic processes (Adedapo et al., 2008). The use of plants with substantial antioxidant activity and with the 
potential to afford protection against ultra-violet radiation is receiving increasing attention (Katiyar et al., 2001). Some 
plant extracts are used as sunscreen against UV rays, to improve skin texture and complexion (Bhat, 2013). Also, 
certain phytochemicals have shown to restrict diffusion of toxins and reduce adverse reactions caused by insect bites 
and stings, calm itching and skin irritation (Finn, 2004).  
The Xhosa people in the Eastern Cape Province, use medicinal plants for the treatment of diseases and in 
rituals. One of the common ritual practices among the Xhosas is the initiation and circumcision of young men every 
year and plant extracts are used to dress and treat the wounds.  
The genus Gnidia belongs to the family Thymelaeaceae and comprises of approximately 152 species; several 
members of which are frequently utilized for treating a variety of ailments. Leaves of G. capitata are used as snuff or 
applied as a poultice for treating toothache, boils, sores, snake bites, bruises and burns (Hutchings and van Staden, 
1994, Philander, 2011). Other uses of Gnidia species include the induction of blistering, treating backache, coughs, 
epilepsy, headache, influenza, fevers, measles, pulmonary tuberculosis, smallpox, snake bites, sprains and tonsillitis 
among others (Bhandurge et al., 2013). This study was carried out to investigate the pharmacological properties of G. 
capitata to treat conditions associated with the skin.  
 
Materials and methods 
Plant collection and preparation 
 
Plant material (bark) was obtained from the Bizana area in the O.R. Tambo municipality district, Eastern Cape 
Province, South Africa. Plants were identified by Dr. Kathleen Immelman of the Kie Herbarium at Walter Sisulu 
University. A voucher specimen (Mahachi 012) was deposited in the herbarium for future reference. Plant material was 
oven dried at 40˚C for 5 days and ground into powder. Thereafter, plant sample was extracted with methanol, ethyl 
acetate and hexane and then filtered using Whatman No. 1 filter paper. Plant extracts were concentrated using a Buchi 
rotatory evaporator R124 and then air-dried under a stream of cold air. Crude extracts were kept at 4˚C in the dark until 
analysis. 
 
Antibacterial activity against Propionibacterium acnes 
 
The minimal inhibitory concentration (MIC) of the G. capitata extracts were determined by microdilution 
assay. This assay was done using methods as described by McGaw and Eloff (2005) and Sahin et al. (2003) with slight 
modifications. The antibacterial activity was investigated against Propionibacterium acnes (ATCC 11827). The 
bacteria were cultured from a Kwik-Stick on nutrient agar and incubated at 37˚C for 72h under anaerobic conditions 
before the assay. The 72h culture was re-suspended in sterile nutrient broth and adjusted to 0.5 McFarland standard 
turbidity. Tetracycline was used as the positive control (Lim et al., 2007). The plates were incubated at 37˚C for 72h in 
anaerobic conditions. The MIC was determined by observing the colour change in the wells after addition of p-
iodonitrotetrazolium violet salt (INT) and was defined as the lowest concentration that showed no colour change.  
 
Colorimetric tyrosinase inhibition assay 
 
The colorimetric tyrosinase assay was performed using methods described by Curto et al. (1999) and Momtaz 
et al. (2008). The source of tyrosinase enzyme used in the experiments was Agaricus bisporus, an edible mushroom 
species which is native to grasslands in Europe and North America. Extracts from G. capitata were dissolved in 
dimethyl sulfoxide (DMSO) to a final concentration of 20mg/ml (stock solution). This stock solution was then diluted 
to 600µg/ml in 50mM potassium phosphate buffer (pH 6.5). Kojic acid was used as the positive control (Lee et al., 
1997). In a 96 well microtitre plate, 70 µl of each sample solution of different concentrations were combined with 30µl 
of tyrosinase (333Units/ml in phosphate buffer, pH 6.5) in triplicates. After incubation at room temperature for 5min, 
110 µl of substrate (2mM L-tyrosine or 12mM L-DOPA) was added to each well. Final concentrations of the extract 
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ranged from 200µg/ml-1.56µg/ml. Microtitre plates were incubated for 30 min at room temperature in a BIO-TEK 
power Wave XS multi-well plate reader and optical density was then determined at 492nm over 30min (A.D.P., 
Weltevreden Park, South Africa). The fifty percent inhibition concentration (IC50) value was determined by the use of 
GraphPad Prism v4.0 software. 
 
Antioxidant activities of G. capitata extract and purified compounds 
 
Antioxidant activity of the various extracts of G. capitata were investigated using the 2.2-diphenyl-1-
picrylhydrazyl (DPPH) (Sigma-Aldrich, South Africa) antioxidant assay. Following the procedures as described by Du 
Toit et al. (2001) for each sample, a series of 8 dilutions was prepared in a 96-well ELISA plate by adding distilled 
water as a diluent. Final concentrations of the samples ranged from 0.78 to 100µg/ml. Each concentration was tested in 
triplicate. Vitamin C was used as the positive control. The radical scavenging capacities of the samples were 
determined using a BIOTEK plate reader to measure the disappearance of DPPH at 550nm. The radical scavenging 
activity was measured based on the amount of antioxidant necessary to decrease the initial DPPH absorbance by 50% 
(IC50) (Du Toit et al., 2001). The IC50 value for each sample was determined graphically by plotting the absorbance of 
DPPH as a function of the sample concentration in µg/ml. The results are expressed as the mg Vit C equivalents/g dry 
weight and are calculated as follows: VitEAC (mg AA/100g) = [IC50 (Vit c)/ IC50 (sample)] x 1000. 
 
In vitro anti-mycobacterial assay 
 
The susceptibility of M. tuberculosis H37Rv (ATCC 27294) to plant extracts was investigated using the 
BACTEC system as described by Lall and Meyer (2001). Plant extracts were re-suspended in DMSO to stock 
concentration of 100 mg/ml. Subsequent dilutions were prepared in DMSO (20, 15, 10, 5, 2.5, 0.5 and 0.2 µg/ml) and 
added to BACTEC 12B vails containing 4ml 7H12 medium PANTA (Becton Dickinson & Company), an antimicrobial 
supplement. The solvent control consisted of a final concentration of DMSO (1%). Drug susceptibility was also 
performed for the standard anti-TB drugs, Streptomycin, Isoniazid (INH) and Ethambutol (Sigma Chemical Co, South 
Africa), at concentrations of 0.2, 6.0 and 7.0µg/ml respectively were used as the positive controls. A homogenous 
culture (0.1ml) of the strains of M. tuberculosis, yielding 1x104 to 1x105 CFU/ml, were inoculated in the vials 
containing the plant extracts as well as in the control vials (Heifets et al., 1985). Two extract-free vials were used as 
controls (medium+1% DMSO): one vial (V1) was inoculated in the same way as the vials containing the extracts, and 
the other (V2) was inoculated with a 1:100 dilution of the inoculum (1:100 control) to produce an initial concentration 
representing a bacterial population of 1x102 to 1x103 CFU/ml found in the vials containing extracts. The MIC was 
defined as the lowest concentration of the extract that inhibited more than 99% of the bacterial population. When 
mycobacteria grow in 7H12 medium containing 14C-labeled substrate (palmitic acid), they utilize the substrate and 
14CO2 is produced. The amount of 14CO2 detected reflects the rate and amount of growth occurring in the sealed vial, 
and is expressed in terms of the Growth Index (GI). Inoculated bottles were incubated at 37˚C and each bottle was 
assayed every day to measure GI, at about the same hour until cumulative results were obtained. The difference in the 
GI values of the last two days is designated as GI. The GI reading of the vials containing the test compound was 
compared with the control vial (V2). Readings were taken until the control vials, containing a 100 times lower dilution 
of the inoculum than the test vials, reached a GI of 30 or more. If the GI value of the vial containing the extract was 
less than the control, the population was reported to be susceptible to the extracts. Each test was replicated three times. 
 
Anticancer activity against the human malignant melanoma cells   
 
The human malignant melanoma cell line, A375, was cultured in complete DMEM supplemented with 10% 
FBS, 15.g/L NaHCO3, 2mM L-glutamine, 10µg/ml penicillin, 10µg/ml streptomycin and 0.25µg/ml fungizone at 37˚C 
in a humidified atmosphere with 5% CO2. A375 cells in DMEM were seeded in sterile 96-well plates at a cell density 
of 104 cells per well. The plates were then incubated for 24 h at 37˚C in a humidified atmosphere with 5% CO2 to allow 
for adherence. The extracts were tested at concentrations ranging from 6.25 - 100µg/ml. Actinomycin D was used as 
the positive control as it shows toxic effects against the cell line. Toxicity was determined 72h after addition of samples 
using the XTT Cell Proliferation II Kit. 
 
Results and discussion  
Antibacterial activity of G. capitata extracts 
 
The results presented in Table 1 showed the antibacterial properties of G. capitata extracts against P. acnes. 
Based on the MIC values, good antibacterial activity against P. acnes was recorded in DCM, EtOAc and n-Hex extracts 
(Table 1). In comparison with the positive control all the crude extracts had good MIC values ranging from 125 -500 
µg/ml. Contrary to a previous study, McGaw et al. (2008) who reported that the methanolic extract of G. capitata had 
good MIC values of 1.6mg/ml against S. aureus however, in the present study a MIC of 500µg/ml was recorded in 
methanolic extract against P. acnes. Gowrish et al. (2016), also reported a MIC (1.5 mg/ml) against Bacillus subtilis 
and Vibro cholerae in pet-ether extracts of Gnidia glauca. The antibacterial activity against P. acnes in the present 
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study provided an insight for the potential use of G. capitata in the treatment of skin related conditions. Phytochemical 
screening has shown that Gnidia species possess a wide range of compounds including polyphenols, daphnane 
diterpenes, lignans and neolignans dimers. These compounds have been implicated in several pharmacological 
properties such as antibacterial, antifungal, antitumor and antimitotic (MacRae and Towers, 1984; Bhandurge et al., 
2013). Perhaps, the inherent phytochemical composition of G. capitata such as polyphenols could be responsible for 
the good antibacterial activity recorded in this study. The results also suggest that potential active compounds could be 
found in the intermediate and non-polar fractions as opposed to those that are soluble in more polar solvents. 
 
Anti-tyrosinase activity of G. capitata extracts 
 
The mushroom tyrosinase inhibitory activity of G. capitata extracts was tested. The anti-tyrosinase inhibitory 
activity showed that all the extracts of G. capitata exhibited IC50 ˃200µg/ml against the enzyme at the highest 
concentration tested. Tyrosinase is known to be a key enzyme in melanin biosynthesis. When the skin is exposed to 
ultraviolet radiation the secretion of melanin is enhanced leading to rapid proliferation of melanocytes (Yasui and 
Sakurai, 2003). Acne condition can also lead to abnormal secretion of melanin which leads to hyperpigmentation of the 
skin. Hence, inhibition of antityrosinase activity could help control the post inflammatory hyperpigmentation 
associated with acne. Tyrosinase inhibitory potential of G. capitata extracts should perhaps be considered using in-
depth screening to further elucidate the mechanism of inhibition. The activity of this extract may not show inhibitory 
activity on the enzyme but could potentially inhibit the transfer of melanin to the epidermis or possibly inhibit 
tyrosinase gene expression.   
  
Anti-mycobacterial activity of G. capitata extracts 
 
Anti-mycobacterial activity of G. capitata is presented in Table 1. In the present study, good anti-
mycobacterial activity against drug-susceptible reference strain M. tuberculosis H37Rv was recorded in the DCM and 
n-Hex extracts.  However, Gowrish et al. (2016) in a similar experiment reported excellent anti-TB activity (25 µg/ml) 
in pet-ether extract of G. glauca against M. tuberculosis H73Rv strain using the Microplate Alamar Blue Assay. 
Perhaps, different solvents used for extraction could be one of the possible explanations for the differences in anti-TB 
activities recorded in the present study. The H37Rv isolate was earlier found to be resistant against some reference 
drugs including rifampicin and isoniazid, in addition to some other first line and second line drugs (Bergval et al., 
2009). Growth inhibition of H37Rv strains by some of the G. capitata extracts reported is an indication that this species 
could be used as a good anti-TB agent against drug resistant strains of M. tuberculosis. However, further studies are 
needed using more isolates/strains of M. tuberculosis as well as the identification of bioactive compounds responsible 
for anti-TB activity. 
 
Table 1: Anti-TB, antioxidant, anti-tyrosinase, anti-acne and anticancer properties of G. capitata extracts. 
Extract and 
positive controls 
Anti-mycobacterial 
MIC1 (µg/ml) 
Antioxidant 
DPPH IC502 
(µg/ml) 
Anti-
tyrosinase 
IC503 (µg/ml) 
Anti-acne 
MIC 
(µg/ml) 
Anti-cancer 
IC50 A375 
cells (µg/ml) 
Methanol >1000 41.83 >200 500 >100 
Ethyl acetate 1000 69.66 >200 125 >100 
DCM 500 88.22 >200 125 >100 
Hexane 500 138.20 >200 125 >100 
Isoniazid 0.20 n/a n/a n/a n/a 
Vitamin C n/a 1.98 n/a n/a n/a 
Kojic acid n/a n/a 3.16 n/a n/a 
Tetracycline n/a n/a n/a 3.1 n/a 
Actinomycin D n/a n/a n/a n/a 4.5 x 10-6 
1 Lowest concentration required to inhibit M. smegmatis growth 
2 Lowest concentration required to scavenge 50% of the DPPH free radical 
3 Lowest concentration required to inhibit 50% of the tyrosinase enzyme activity 
4 Lowest concentration required to inhibit the growth of P. acnes 
5 Lowest concentration required to inhibit 50% of A375 cell viability 
 
Antioxidant activity of G. capitata extracts 
 
The antioxidant DPPH scavenging activity of G. capitata extracts is presented in Table 1. DPPH is a relatively 
stable nitrogen centred free radical that easily accepts an electron by reacting with suitable reducing agents. As a result, 
the electrons become paired off and the DPPH solution losses its violet colour depending on the number of electrons 
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taken up (Blois, 1958). The highest quenching activity was recorded in methanolic extract with an IC50 value of 41.83 
µg/ml followed by ethyl acetate extract then the DCM extract. The lowest DPPH activity was recorded in n-Hex 
extract. The Xhosa people in the Eastern Cape Province use extracts of G. capitata as sun screen indicating that this 
plant species has the capacity to prevent the pernicious effects of ultraviolet radiation from the sunlight which is the 
most common exogenous to the skin. Perhaps, the extracts of G. capitata not only act as sunscreen but might also 
maintain the linearity of dermal elastic fibres of the skin, reduce collagen degeneration which induces wrinkling and 
sagging, resulting in aging appearance of the skin. However, further studies are required to understand the exact 
mechanism of action by using fractions, semi pure and pure compounds of G. capitata in different assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The dose-response curves of the inhibition of DPPH free radicals for the a) methanol b) ethyl acetate c) 
dichloromethane and d) hexane extracts tested at different concentrations compared with e) Vitamin C, a known 
scavenger of DPPH free radicals  
 
Anti-cancer activity  
 
Melanoma is defined as a tumour formed in melanocytes (melanin-forming cells). This is often a malignant 
tumour associated with skin cancer. The cytotoxic activity of G. capitata against epidermal malignant melanoma A375 
is presented in Table 1. All the extracts tested in the present study showed no activity at the highest concentration tested 
(100µg/ml) against the proliferation of melanoma cells.  
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Conclusion 
 
The results of this study may explain the use of G. capitata for the treatment of skin related conditions among 
the Xhosas taking into account the fact that extracts exhibited low to moderate activity when the values obtained are 
compared to the positive standards in each model. The various extracts of G. capitata showed the best potential as 
either an anti-acne agent using non-polar solvent extraction and potentially as a sun protection factor (SPF) product 
using more polar solvents such as methanol. The bioassay-guided isolation and structure elucidation could be beneficial 
to determine which types of compounds could be responsible for the antibacterial and antioxidant activity and whether 
activity of these is better alone or within the crude extract. Many other species of Gnidia have been tested, however, G. 
capitata is relatively understudied.   
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